UNICA IRIS Institutional Research Information System

PAOLETTI, ANNA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 270.669
NA - Nord America 18.923
AS - Asia 8.983
SA - Sud America 1.408
AF - Africa 197
Continente sconosciuto - Info sul continente non disponibili 32
OC - Oceania 26
Totale 300.238
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 233.137
NL - Olanda 30.580
US - Stati Uniti d'America 18.646
SG - Singapore 3.502
CN - Cina 3.371
UA - Ucraina 2.161
SE - Svezia 1.326
DE - Germania 1.221
BR - Brasile 1.111
FI - Finlandia 762
VN - Vietnam 719
FR - Francia 538
GB - Regno Unito 500
HK - Hong Kong 327
KR - Corea 253
IN - India 194
RU - Federazione Russa 176
CA - Canada 167
AR - Argentina 103
BD - Bangladesh 96
MX - Messico 68
IQ - Iraq 67
JP - Giappone 58
ZA - Sudafrica 52
PK - Pakistan 51
EC - Ecuador 50
PH - Filippine 45
TR - Turchia 44
ID - Indonesia 38
PL - Polonia 38
CO - Colombia 34
EU - Europa 31
AT - Austria 30
MA - Marocco 30
VE - Venezuela 30
BE - Belgio 28
ES - Italia 27
MY - Malesia 25
UZ - Uzbekistan 24
CL - Cile 23
SA - Arabia Saudita 23
RO - Romania 22
TN - Tunisia 21
AU - Australia 20
PY - Paraguay 20
KE - Kenya 19
UY - Uruguay 19
IE - Irlanda 18
IL - Israele 16
NP - Nepal 16
CZ - Repubblica Ceca 15
EG - Egitto 15
JO - Giordania 15
ET - Etiopia 14
LT - Lituania 13
CH - Svizzera 12
AZ - Azerbaigian 11
PE - Perù 11
AE - Emirati Arabi Uniti 10
PT - Portogallo 10
DZ - Algeria 9
IR - Iran 9
LB - Libano 9
KZ - Kazakistan 8
MU - Mauritius 8
SN - Senegal 8
TH - Thailandia 8
BG - Bulgaria 7
BO - Bolivia 7
CR - Costa Rica 7
DO - Repubblica Dominicana 7
HN - Honduras 7
JM - Giamaica 7
MD - Moldavia 7
NO - Norvegia 7
AL - Albania 5
AO - Angola 5
DK - Danimarca 5
GR - Grecia 5
KG - Kirghizistan 5
NZ - Nuova Zelanda 4
OM - Oman 4
PS - Palestinian Territory 4
RS - Serbia 4
TW - Taiwan 4
GE - Georgia 3
GT - Guatemala 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
NG - Nigeria 3
PR - Porto Rico 3
QA - Qatar 3
SY - Repubblica araba siriana 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
CY - Cipro 2
GA - Gabon 2
KH - Cambogia 2
LK - Sri Lanka 2
Totale 300.202
Salva come PNG Salva come JPEG
Città #
Cagliari 226.546
Amsterdam 30.533
Uta 4.957
Fairfield 1.714
Singapore 1.714
Ashburn 1.559
Woodbridge 1.242
Chandler 1.196
San Jose 1.180
Jacksonville 1.154
Boardman 1.047
Dallas 925
Wilmington 888
Ann Arbor 858
Houston 776
Seattle 724
Nyköping 690
Cambridge 568
Beijing 492
Helsinki 430
Dearborn 387
Nanjing 375
Hefei 340
Los Angeles 323
Hong Kong 298
Lauterbourg 298
Boston 278
Seoul 230
Ho Chi Minh City 229
Santa Clara 202
Buffalo 175
The Dalles 163
Hanoi 153
Milan 151
Shenyang 116
San Diego 113
New York 112
Shanghai 108
Nanchang 105
Tianjin 99
Toronto 99
Guangzhou 96
Changsha 78
Hebei 76
Jiaxing 74
Redwood City 74
São Paulo 71
Rome 65
Mountain View 62
Redondo Beach 60
Verona 58
London 57
Council Bluffs 54
Jinan 54
Norwalk 51
Orange 51
Frankfurt am Main 50
Orem 49
Chicago 48
Washington 46
Sassari 45
Tokyo 45
Rio de Janeiro 40
Munich 39
Dong Ket 34
Ningbo 34
Zhengzhou 33
Auburn Hills 32
Da Nang 32
Nuremberg 31
Warsaw 30
Brooklyn 29
Columbus 28
Belo Horizonte 27
Johannesburg 26
Pune 26
Atlanta 25
Haiphong 25
Curitiba 24
Tashkent 23
Baghdad 22
Brussels 22
Kunming 22
San Francisco 22
Campinas 21
Hải Dương 21
Redmond 21
Taizhou 21
Chennai 20
Saint Petersburg 20
Hangzhou 19
Montreal 18
Phoenix 18
Guayaquil 17
Manchester 17
Mexico City 17
Molise 17
Mumbai 17
Nairobi 17
Stockholm 17
Totale 285.735
Salva come PNG Salva come JPEG
Nome #
Long-acting reversible contraception (LARC) with the intrauterine system with levonorgestrel (6 mcg/d): observational study on the acceptability, quality of life, and sexuality in Italian women 4.109
Overview of elagolix for the treatment of endometriosis 3.527
Urinary metabolomics of pregnant women at term: a combined GC/MS and NMR approach 3.399
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: a prospective one-year evaluation 3.389
Systemic therapy for the treatment of endometrial cancer 3.106
Vaginosi batterica: efficacia di un trattamento locale con un gel vaginale a base di una frazione batterica derivata da Propionibacterium acnes 3.043
The stimulation of the vaginal immune system with short-term administration of a vaginal gel containing fraction of Propionibacterium acnes, hyaluronic acid and polycarbophil is efficacious in vaginal infections dependent on disorders in the vaginal ecosystem 2.991
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 2.970
Olfactory performance in relation to sex and hormonal profile in humans 2.917
Repeated two cycles of ulipristal acetate treatment improve the quality of life in premenopausal women with heavy menstrual bleeding dependent on uterine myomas, without impairment of bone health 2.916
Prophylaxis of peripartum haemorrhage using recombinant factor VIIa (rfVIIa) in pregnant women with congenital factor VII deficiency: A case report and literature review 2.752
Body composition and psychological improvement in healthy premenopausal women assuming the oral contraceptive containing micronized estradiol (E2) and nomegestrol acetate (NOMAC) 2.743
Research development of a new GnRH antagonist (Elagolix) for the treatment of endometriosis: a review of the literature 2.695
Studio epidemiologico sull’osteoporosi postmenopausale 2.588
Vilaprisan for treating uterine fibroids 2.560
Dismenorrea e endometriosi: una innovativa alternativa alla terapia farmacologica nel controllo del dolore 2.479
Interference of dopamine infusion on gamma-amino butyric acid (GABA)-stimulated prolactin increase 2.460
Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy 2.440
Inhibitory effect of the dopamine agonist bromocriptine on the postcastration gonadotrophin rise in women 2.425
Critical reappraisal of the clinical effectiveness of different methods of assisted fertilization 2.413
Changes of olfactory sensitivity related to sex and hormonal profile in humans 2.387
Placental biomarkers 2.354
Clinical utility of elagolix as an oral treatment for women with uterine fibroids: A short report on the emerging efficacy data 2.352
Norethisterone enanthate as an injectable contraceptive in puerperal and non-puerperal women 2.309
Radioimmunological determination of apparent free progesterone concentration in plasma samples of pregnant and non-pregnant women 2.294
Studio osservazionale sul contraccettivo ormonale contenente estradiolo valerato e dienogest in formulazione quadrifasica: accettabilità, effetto favorevole sulla composizione corporea e sullo stato psicologico. 2.230
“CG Fem, PI 82, Vitamina E” per la terapia della menopausa: quali vantaggi per la sintomatologia neurovegetativa peri-post menopausale 2.216
Placental growth factor and preterm delivery 2.158
Pharmacologic induction of multiple follicular development improves the success rate of artificial insemination with husband's semen in couples with male-related or unexplained infertility 2.078
Influence of oestradiol and progesterone on pulsatile LH secretion in postmenopausal women 2.075
Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment 2.068
Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women 2.049
Unbalanced progesterone and estradiol secretion in catamenial epilepsy 2.047
Risultati di uno studio pilota sull’efficacia del palmitoiletanolamide + transpolidatina in donne con endometriosi 2.037
Resistenza all’insulina nella PCOS e trattamento con inositolo e acido alfa-lipoico 2.031
Interaction between veralipride and the endogenous opioid system in the regulation of body temperature in postmenopausal women 2.029
Prevention of postmenopausal bone loss and endometrial responses during a two year prospective study with transdermal 17 beta-estradiol and oral medroxyprogesterone acetate 2.029
Studio osservazionale sul contraccettivo ormonale a base di E2 1,5 mg/NOMAC 2,5 mg in formulazione monofasica 2.028
Regulation of body temperature in postmenopausal women: interactions between bromocriptine and the endogenous opioid system 2.025
Effects of transdermal 17 beta-estradiol treatment and naloxone infusion on gonadotropin response to gonadotropin-releasing hormone in postmenopausal women 1.989
Maternal perinatal depression, anxiety, fear of birth, and perception of infants’ negative affectivity at three months 1.986
Contraception in chronic kidney disease: a best practice position statement by the kidney and pregnancy group of the Italian Society of Nephrology 1.967
Ultrasonographic soft markers for detection of rectosigmoid deep endometriosis 1.938
Screening e diagnosi del Diabete Gestazionale in Sardegna: risultati a confronto. 1.914
Il bi-test: solo screening di cromosomopatie fetali? 1.899
STUDIO OSSERVAZIONALE SUL CONTRACCETTIVO ORMONALE A BASE DI ESTRADIOLO (E2) 1.5 MG/NOMEGESTROLO (NOMAC) 2.5 MG IN FORMULAZIONE MONOFASICA: ACCETTABILITA', EFFETTO FAVOREVOLE SULLA COMPOSIZIONE CORPOREA E SUI PARAMETRI ANTROPOMETRICI 1.897
Modificazioni dell’umore e del comportamento nel puerperio: quali fattori di rischio? 1.894
SARCOPENIA: DIAGNOSI E PROSPETTIVE TERAPEUTICHE 1.888
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 1.814
Monurelle Biogel® vaginal gel in the treatment of vaginal dryness in postmenopausal women 1.811
Adherence with ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen supported by the use of a digital tablet dispenser with or without acoustic alarm: an open-label, randomized, multicenter study 1.806
Menopause and hormone replacement therapy: the 2017 Recommendations of the Italian Menopause Society 1.804
Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 mu g of ethinyl estradiol 1.766
Autoimmunity in gestational diabetes mellitus in Sardinia: a preliminary case-control report 1.763
Fattore di Crescita Placentare (PlGF): correlazioni con la funzione placentare 1.763
Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study 1.745
Modificazione dell'umore in gravidanza e nel post-partum: ruolo degli integratori 1.735
Successful laparoscopic management of a giant ovarian cyst 1.725
Diagnosi isteroscopica del tumore endometriale: nostra esperienza 1.705
Changes in GABAA receptor gamma2 subunit gene expression induced by long-term administration of oral contraceptives in rats 1.681
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group 1.663
Confronto tra diagnosi isteroscopica e istologica delle patologie endometriali maligne, nostra esperienza 1.605
Contraception with estradiol valerate and dienogest: adherence to the method 1.591
CARATTERISTICHE DELLA "MESTRUAZIONE", DELLA PRESSIONE ARTERIOSA E DEI SINTOMI PSICOLOGICI IN CORSO DI SEI CICLI DI TRATTAMENTO CON IL CONTRACCETTIVO ORMONALE A BASE DI E2 1.5 MG/NOMAC 2.5 MG 1.586
Large twisted ovarian fibroma associated with Meigs' syndrome, abdominal pain and severe anemia treated by laparoscopic surgery 1.575
Observational study on the stability of the psychological status during normal pregnancy and increased blood levels of neuroactive steroids with GABA-A receptor agonist activity. 1.559
STUDIO OSSERVAZIONALE SUL CONTRACCETTIVO ORMONALE CONTENENTE ESTRADIOLO VALERATO E DIENOGEST IN FORMULAZIONE QUADRIFASICA: ACCETTABILITA', EFFETTO FAVOREVOLE SULLA COMPOSIZIONE CORPOREA E SULLO STATO PSICOLOGICO 1.535
Gamma-amino-beta-hydroxy butyric acid stimulates prolactin and growth hormone release in normal women 1.532
Osteoporosis's Menopausal Epidemiological Risk Observation (O.M.E.R.O.) study 1.508
Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel 1.493
LE ALTERAZIONI DELLA FASE OVULATORIA 1.458
Non-hormonal strategies for managing menopausal symptoms in cancer survivors: an update 1.447
XO/XY mosaicism with non fluorescent Y chromosome: clinical, cytogenetic and endocrinological studies on a female subject 1.433
Macro-regional variation in attitudes toward and experiences of vulvar and vaginal atrophy among Italian post-menopausal women: a post hoc analysis of REVIVE survey data 1.416
Low androgenization index in elderly women and elderly men with Alzheimer's disease 1.391
Placental growth factor and placental perfusion 1.389
Efficacy of intravenous tramadol treatment for reducing pain during office diagnostic hysteroscopy 1.384
Relevant changes in nephrogenesis in Down syndrome 1.373
Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women 1.367
Left : right side ratio of endometriotic implants in the pelvis 1.359
INDICAZIONE AL PARTO CESAREO PRESSO LA CLINICA OSTETRICA E GINECOLOGICA DI CAGLIARI: SU QUALI POSSIAMO RIDURRE IL RICORSO AL PARTO CESAREO? 1.358
The oral contraceptive containing 30 microg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle: an observational study 1.352
Soy isoflavones, inulin, calcium, and vitamin D3 in post-menopausal hot flushes: an observational study 1.342
Apparent free cortisol concentration in normal men, non-pregnant, pregnant and postmenopausal women 1.322
The screening of tubal abnormalities in the infertile couple 1.309
Pattern of bone markers during pregnancy and their changes after delivery. 1.303
Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 mu g of ethinyl estradiol: observational study in young postadolescent women 1.299
Evidence that in healthy young women, a six-cycle treatment with oral contraceptive containing 30 mcg of ethinylestradiol plus 2 mg of chlormadinone acetate reduces fat mass 1.298
Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women 1.286
ANALGESIA EPIDURALE E INCIDENZA DI TAGLIO CESAREO. 1.277
Placental massive perivillous fibrin deposition after a previous uncomplicated term pregnancy: report of two cases. 1.258
EZIOPATOGENESI DEI MIOMI UTERINI 1.246
B-mode and Power Doppler Ultrasound in Adnexsal Masses 1.224
The effect of vulvovaginal atrophy on women’s quality of life from an Italian cohort of the EVES study 1.201
Observational study on the efficacy of tibolone in counteracting early carotid atherosclerotic lesions in postmenopausal women 1.200
The treatment of polycystic ovary syndrome 1.180
Correlazioni tra composizione corporea ed età 1.179
The impact of COVID-19 lockdown on admission to gynecological emergency departments: Results from a multicenter Italian study 1.137
Reflections and recommendations on the COVID-19 pandemic: Should hormone therapy be discontinued? 1.097
The 12-month treatment with the oral contraceptive formulation containing dienogest (DNG) and estradiol valerate (E2V) shows beneficial effects on psychological symptoms: results from a prospective comparative study with a formulation containing ethinyl estradiol (EE) and drospirenone (DRSP) 1.088
Totale 191.828
Salva come PNG Salva come JPEG
Categoria #
all - tutte 414.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 414.259
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.839 0 0 0 0 0 0 0 0 0 0 2.495 1.344
2021/202213.719 1.339 1.099 581 1.097 1.273 1.049 1.223 678 1.119 1.172 1.516 1.573
2022/202319.530 2.034 2.185 2.190 1.436 1.536 1.748 773 3.042 1.287 981 1.548 770
2023/202425.933 1.565 1.429 1.192 1.953 2.807 4.246 4.430 1.463 1.198 1.745 2.055 1.850
2024/202541.293 4.382 6.941 5.441 4.813 2.487 4.475 3.433 302 709 6.868 561 881
2025/202637.633 795 924 2.066 1.451 922 1.163 2.292 690 25.404 1.884 42 0
Totale 300.689